Advertisement
Clinical guidance for our most vulnerable patients
Coordinating care across multiple disciplines
Multidisciplinary treatment of rare and complex immunodeficiencies
The potential for safer therapies
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Patient reported outcomes differentiate between remission and low disease activity in PsA
Prevention of progression and complications is the primary goal
A unique approach provides long-lasting results with minimal impact on the disease state
A broad differential diagnosis
Results of the largest population-based study to date
Scientific evidence for and clinical experience of using JAK inhibitors in the treatment of COVID-19
Advertisement
Advertisement